Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huue has developed and scaled a proprietary microbial fermentation process to produce biosynthetic indigo dye as a sustainable alternative to petroleum-based and toxic chemical dyes. Their product matches conventional indigo in performance but with significantly reduced toxicity and environmental impact. The technology has been demonstrated at industrial scale with denim manufacturers and continues to expand into other colorants. Huue’s biotechnology doesn’t rely on fossil fuels of any kind, enabling a cleaner, greener blue... Our team first examines how color compounds occur in nature. From there, we leverage proprietary bioengineering to create microbes that mirror nature’s process and consume sugar to enzymatically produce dye. Huue discovered a way...to create indigo (and other colors) from completely renewable sources like sugar and microbes. They’ve programmed bacteria...proven that their dyes perform just as well as the toxic ones. No clinical results since this company does not operate in human health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huue.